GSK venture files lawsuit Zurich Insurance beats 2017 profit estimates, raises dividend Finland's Solidium sells Telia stake for 5.1 bln SEK Thomas Cook expands airline business by 10 pct for this summer TDC rejects takeover offer from …
Nomura maintains a reduce rating on GSK Pharma and has also slashed its 12-month target ... However, the market expects strong revival in EBITDA margins and the stock is factoring in possible delisting if parent Glaxo Plc buys back …
GSK’s Emma Walmsley’s first 25 days. FT Opening Quote, with commentary by Matthew ... remains a compelling alternative for consumers and businesses alike. But London Stock Exchange chief executive Xavier Rolet has the …
KARACHI: GlaxoSmithKline Consumer Healthcare Pakistan Limited (GSKCH) got listed at the Pakistan Stock Exchange (PSX) on Wednesday and its share price shot to the one-day maximum high limit of 5% in no time after …
GSK sells HIV medicines through its majority-owned ViiV Healthcare unit, which it had been considering for a stock market listing, until a change of tack on May 6. Its investment at Chapel Hill is separate from ViiV, although ViiV will play an …
India has revoked a patent granted to GlaxoSmithKline Plc for breast cancer drug Tykerb ... ranging from corruption and pricing probes in China to stock management problems in Brazil.
Research Triangle Park, N.C. — Drug giants GlaxoSmithKline (NYSE ... Pfizer Chief Executive Officer Jeff Kindler in a joint statement issued to the London Stock Exchange. "With the strength of the companies' current HIV products, as …
UK pharma giant GlaxoSmithKline plc (LON ... We’ve bounced off that at £14.50 so that looks like a technical buy signal.”
Glaxosmithkline, the pharmaceuticals group, is pressing the Government to force tobacconists and newsagents to stock anti-smoking products prominently alongside cigarettes. The proposal is at the heart of GSK's submission to the …